These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15828099)

  • 21. Acquired factor VIII inhibitor in an HIV-infected patient after treatment with pegylated interferon-alpha 2a and ribavirin.
    Paul S; Javed U; Tevendale R; Lanford J; Liu R
    AIDS; 2007 Mar; 21(6):784-5. PubMed ID: 17413709
    [No Abstract]   [Full Text] [Related]  

  • 22. [ANRS HC 02 RIBAVIC: from multicenter trial to daily practice. Conclusions].
    Pol S
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S118-9. PubMed ID: 19375040
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of hepatitis C in HIV infected and other immunocompromised individuals.
    Seth AK
    Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of romiplostim allows for hepatitis C therapy in a HIV/HCV coinfected patient.
    Taylor N; Melchardt T; Grundbichler M; Strasser M; Egle A; Greil R
    Ann Hematol; 2013 Jul; 92(7):1001-2. PubMed ID: 23269533
    [No Abstract]   [Full Text] [Related]  

  • 25. [HIV/HCV coinfection: 40% of patients can successfully be treated].
    Dtsch Med Wochenschr; 2004 Apr; 129(16):911. PubMed ID: 15134089
    [No Abstract]   [Full Text] [Related]  

  • 26. HIV/HCV coinfection in clinical practice.
    Dieterich DT; Kontorinis N; Agarwal K
    J Int Assoc Physicians AIDS Care (Chic); 2004 Oct; 3 Suppl 1():S4-14; quiz S16-7. PubMed ID: 15566014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic and renal safety profile of tenofovir in HIV-infected patients with hepatitis C, including patients on interferon plus ribavirin.
    Sánchez-Conde M; Gil P; Sánchez-Somolinos M; Gonzalez-Lahoz J; Soriano V
    HIV Clin Trials; 2005; 6(5):278-80. PubMed ID: 16306034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Primer treatment of acute and chronic hepatitis C].
    Daruich J; Fainboim H; Frider B
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S52-6; discussion S74-82. PubMed ID: 16862862
    [No Abstract]   [Full Text] [Related]  

  • 29. [ANRS HC 02 RIBAVIC: from multicenter trial to daily practice].
    Pol S
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S91-3. PubMed ID: 19375041
    [No Abstract]   [Full Text] [Related]  

  • 30. Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.
    Ramos B; Núñez M; Rendón A; Berdún MA; Losada E; Santos I; Echevarría S; Ocampo A; Miralles C; Arazo P; Barreiro P; Romero M; Labarga P; Guardiola JM; Garcia-Samaniego J; Soriano V
    J Viral Hepat; 2007 Jun; 14(6):387-91. PubMed ID: 17501758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV and hepatitis co-infection: a consensus for treatment?
    Lumb J
    Lancet Infect Dis; 2005 Apr; 5(4):202. PubMed ID: 15834972
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.
    Pineda JA; Mira JA; Gil Ide L; Valera-Bestard B; Rivero A; Merino D; Girón-González JA; Ríos-Villegas MJ; González-Serrano M; Collado A; García-García JA; Carrillo-Gómez R; López-Cortés LF; Gómez-Mateos J
    J Antimicrob Chemother; 2007 Dec; 60(6):1347-54. PubMed ID: 17938129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of rapid virological response in prediction of sustained virological response to Peg-IFN plus ribavirin in HCV / HIV co-infected individuals.
    Shea DO; Tuite H; Farrell G; Codd M; Mulcahy F; Norris S; Bergin C
    J Viral Hepat; 2008 Jul; 15(7):482-9. PubMed ID: 18221297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Workshop report treating hepatitis C in HIV-infected patients: where are we now?
    Perronne C
    Antivir Ther; 2005; 10(5):691-4. PubMed ID: 16152763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV and hepatitis C virus coinfection: bad bedfellows.
    Schooley RT
    Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treating hepatitis C in patients with cirrhosis: the effort is worth it.
    Forns X; Bruix J
    J Hepatol; 2010 May; 52(5):624-6. PubMed ID: 20334945
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment algorithm for the management of hepatitis C in HIV-coinfected persons.
    Sulkowski MS
    J Hepatol; 2006; 44(1 Suppl):S49-55. PubMed ID: 16360232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
    Martin-Carbonero L; Nuñez M; Mariño A; Alcocer F; Bonet L; García-Samaniego J; López-Serrano P; Cordero M; Portu J; Soriano V
    AIDS; 2008 Jan; 22(1):15-21. PubMed ID: 18090387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon.
    Aguilar Marucco D; Gonzalez de Requena D; Bonora S; Tettoni C; Bonasso M; De Blasi T; D'Avolio A; Sciandra M; Siccardi M; Baietto L; Trentini L; Sinicco A; Cariti G; Di Perri G
    J Antimicrob Chemother; 2008 Apr; 61(4):919-24. PubMed ID: 18238889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
    Taylor LE; Rich JD; Tashima KT
    N Engl J Med; 2004 Nov; 351(22):2340-2; author reply 2340-2. PubMed ID: 15564553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.